FINWIRES · TerminalLIVE
FINWIRES

Mary Chia Flags Net Loss in Fiscal 2026

By

Mary Chia (SGX:5OX) expects to book a net loss for the fiscal year ended March 31, compared to net profit a year earlier, according to a Tuesday bourse filing.

The wellness company attributed the expected loss to lower revenue contribution and higher operating and fulfilment related costs from Taiwan operations, higher depreciation of right-of-use assets, and higher finance costs stemming from increased borrowings.

The company will release its financials on or before May 29.

Related Articles

Asia

Powermatic Data Systems' Attributable Profit Increases Fiscal H2

Powermatic Data Systems' (SGX:BCY) attributable profit to owners jumped in the fiscal second half ended March 31 to SG$11.6 million from SG$2.2 million a year earlier, according to a Tuesday bourse filing.Earnings per share came in at SG$0.3296 compared with SG$0.0626 in the year-ago period.Revenue surged year over year to SG$22.3 million from SG$6.9 million, backed by strong performances from the property development segment.The designer and manufacturer of wireless connectivity devices declared a final dividend of SG$0.04 per share and a special dividend of SG$0.0015 per share.

$SGX:BCY
Asia

China International Suffers Legal Setback Over Construction Debt

China International's (SGX:BEH) subsidiaries, Group, namely CIHL (Tianjin) City Development and Yichang Zhongjia Xinye Asset Management, received a first-instance judgment from the Yilin District Court of Yichang City, according to a Tuesday bourse filing.Based on the hearing, the two companies have been ordered to bear joint liability for debts owed to Hunan Construction Engineering of up to 11 million yuan and 739,074 yuan respectively.The company had already made provisions in its accounts and added that there will be no impact on its financial performance due to the verdict.

$SGX:BEH
Asia

Buchang Pharma Subsidiary Adds Health Food to Business Scope

Shandong Buchang Pharmaceuticals (SHA:603858) subsidiary Shandong Buchang Qihang Pharmaceutical Sales added pre-packaged health food sales to its business scope.The change was made due to operational and management needs, according to a Tuesday filing with the Shanghai bourse.

$SHA:603858